Norepinephrine is titrated by starting at a standard infusion rate, then adjusting the dose every few minutes based on blood pressure readings until the target is reached. The goal in most critically ill patients is a mean arterial pressure (MAP) of at least 65 mmHg, though individual targets vary. The process requires continuous monitoring and a systematic approach to dose changes.
Starting the Infusion
The typical starting rate for adults is 8 to 12 mcg/min, delivered through a continuous intravenous infusion pump. From there, the rate is increased or decreased based on the patient’s blood pressure response. Some facilities use weight-based dosing (mcg/kg/min) rather than a flat rate. Research comparing the two approaches found that weight-based dosing resulted in lower initial doses without delaying the time to reach the blood pressure goal, though clinicians less familiar with it tended to keep patients on the infusion longer.
The choice between weight-based and non-weight-based dosing often depends on institutional protocol. Norepinephrine has a low volume of distribution and concentrates in sympathetic nervous system tissues, so body size doesn’t affect the dose as predictably as it does for many other medications. That said, patients with more body fat may have more receptors that norepinephrine binds to, which can increase their dose requirements.
How to Adjust the Dose
During the initial titration phase, blood pressure should be checked every 2 to 3 minutes if noninvasive monitoring is being used. Most ICU patients will have an arterial line providing continuous readings, which makes real-time adjustments easier. Once a stable maintenance dose is identified, noninvasive checks can stretch to at least every 5 minutes.
Dose adjustments are made in small, consistent increments. The size of each increment varies by protocol, but the principle is the same: increase the rate, observe the response over a few minutes, and adjust again if the target MAP hasn’t been reached. Overshooting the target with large jumps risks dangerous spikes in blood pressure, while moving too slowly leaves the patient in prolonged shock. The key is steady, measured increases with a pause between each one to let the drug take effect.
The MAP Target
The Surviving Sepsis Campaign guidelines recommend targeting a MAP of at least 65 mmHg as the initial resuscitation goal. This threshold reflects the minimum pressure needed to perfuse vital organs, particularly the kidneys and brain.
Not every patient should be held to exactly 65. Patients with a history of chronic high blood pressure or significant atherosclerosis may need a higher target to maintain adequate organ perfusion, since their bodies have adapted to operating at higher pressures. A large trial published in the New England Journal of Medicine confirmed that these patients often benefit from a higher MAP goal, while targeting 65 remains appropriate for most others.
Monitoring Beyond Blood Pressure
MAP is the primary number guiding titration, but it’s not the only sign that the dose is working. Several other markers help determine whether organs are actually receiving enough blood flow:
- Urine output: checked hourly, it reflects whether the kidneys are getting adequate perfusion. A drop suggests the dose may need to go up or that something else is going wrong.
- Lactate levels: elevated lactate indicates tissues aren’t getting enough oxygen. A falling lactate trend is one of the most reassuring signs that resuscitation is working.
- Skin color and temperature: cool, mottled, or pale extremities suggest poor peripheral perfusion even if the MAP number looks acceptable.
- Heart rate and rhythm: monitored continuously, since norepinephrine stimulates the heart and can provoke abnormal rhythms at higher doses.
- Central venous oxygen saturation: measures how much oxygen is left in the blood returning to the heart, offering a window into whether tissues are extracting oxygen normally.
Kidney function labs, blood gases, electrolytes, and glucose are also tracked at regular intervals. The overall picture matters more than any single number. A patient whose MAP is 65 but whose lactate is climbing and urine output is dropping is not adequately resuscitated, regardless of what the blood pressure reading says.
When to Add a Second Vasopressor
There is a practical ceiling for norepinephrine. Current Surviving Sepsis Campaign guidelines suggest adding vasopressin when the norepinephrine dose reaches roughly 0.25 to 0.5 mcg/kg/min and the MAP target still hasn’t been met. Vasopressin works through a completely different mechanism, so it complements norepinephrine rather than simply stacking more of the same effect.
If the combination of norepinephrine and vasopressin still isn’t enough, epinephrine is the next agent typically added. The need for multiple vasopressors signals severe shock, and the clinical team will be reassessing the underlying cause aggressively at that point.
Peripheral vs. Central Line Administration
Norepinephrine has traditionally required a central venous catheter because of the risk of tissue damage if the drug leaks out of the vein (extravasation). However, newer protocols allow peripheral administration under specific conditions: the IV catheter must be an appropriate size, placed in an approved location, and confirmed with ultrasound. The infusion site needs regular checks to ensure the vein is still intact and the patient can report any pain or discomfort at the site.
Peripheral protocols typically cap the dose at 15 mcg/min and may limit infusion duration to 48 hours, after which a central line becomes mandatory for continued administration. These safeguards exist because extravasation of norepinephrine causes intense constriction of local blood vessels, which can lead to tissue death if not treated quickly.
Managing Extravasation
If norepinephrine leaks into surrounding tissue, the affected area typically becomes cold, hard, and pale. The standard rescue treatment is injecting a solution that blocks the drug’s vessel-constricting effect directly into the damaged area. This involves diluting 5 to 10 mg of an alpha-blocking agent in 10 to 15 mL of saline and infiltrating it through multiple small injections around the extravasation site using a fine-gauge needle. The treatment needs to happen as quickly as possible after the leak is identified, since tissue damage progresses rapidly.
Weaning Off Norepinephrine
Once the underlying cause of shock is being treated and the patient stabilizes, the titration process reverses. The dose is gradually reduced in small decrements while watching for any drop in MAP or signs of worsening perfusion. Weaning too quickly can cause rebound hypotension, so the same patience that applies during escalation applies during de-escalation. If a second vasopressor was added, it’s typically weaned first, with norepinephrine being the last agent discontinued since it’s the most effective first-line option.